SRPK1 inhibitors

Anti-angiogenic treatments, for example treatment of ocular neovascularization or cancer, treatments of hyperpermeability disorders, treatments of neuropathic and neurodegenerative disorders, pain treatments, methods of treating or preventing fibrosis and compounds for use in such methods are descri...

Full description

Saved in:
Bibliographic Details
Main Authors MORLEY, Andrew David, BAXTER, Andrew Douglas, MORRIS, Jonathan
Format Patent
LanguageEnglish
Published 13.04.2023
Subjects
Online AccessGet full text

Cover

Loading…